v3.25.2
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

The following table discloses any officer (as defined in Rule 16a-1(f) under the Exchange Act) or director who entered into, modified or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K) during the three months ended June 30, 2025:

Name and Title

 

Type of Trading Arrangement

 

Action Taken
(Date of Action)

 

Duration or End Date

 

Aggregate Number of Securities to be Sold

 

Description of Trading Arrangement

William Savage, M.D., Ph.D.
Chief Medical Officer

 

Trading plan intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c)

 

Adoption
(June 26, 2025)

 

End Date
(February 27, 2026)

 

Up to 13,093

 

Sale
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Rule 10b5-1 Arrangement Modified false
Non-Rule 10b5-1 Arrangement Modified false
William Savage [Member]  
Trading Arrangements, by Individual  
Name William Savage
Title Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 26, 2025
Expiration Date February 27, 2026
Arrangement Duration 246 days
Aggregate Available 13,093